Jubilant DraxImage receives approval for new pulmonary indications from the
U.S. Food and Drug Administration for DRAXIMAGE® DTPA
02 janv. 2018 10h45 HE
|
Jubilant DraxImage
Montreal, QC, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Jubilant DraxImage Inc. (“DraxImage”), a Jubilant Pharma wholly-owned subsidiary, is pleased to announce approval of new pulmonary indications for...